Omeros Corporation Share Price: OMER (Omeros Corporation) Stock Price Today & Updates | INDmoney

Question 1

What is Omeros Corporation share price today?

Accepted Answer

Omeros Corporation (OMER) share price today is {{live_price}}.

Question 2

Can Indians buy Omeros Corporation shares?

Accepted Answer

Yes, Indians can invest in the Omeros Corporation (OMER) from India.

With INDmoney, you can buy Omeros Corporation at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Omeros Corporation at zero transaction cost.

Question 3

How can I buy Omeros Corporation shares from India?

Accepted Answer

It is very easy to buy Omeros Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Omeros Corporation be purchased?

Accepted Answer

Yes, you can buy fractional shares of Omeros Corporation with INDmoney app.

Question 5

What are the documents required to start investing in Omeros Corporation stocks?

Accepted Answer

To start investing in Omeros Corporation, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Omeros Corporation

Accepted Answer

Today’s highest price of Omeros Corporation (OMER) is {{1_rba_end}}.

Today’s lowest price of Omeros Corporation (OMER) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Omeros Corporation

Accepted Answer

Today's market capitalisation of Omeros Corporation OMER is 234.7M

Question 8

What is the 52 Week High and Low Range of Omeros Corporation

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Omeros Corporation is down from its 52 Week High?

Accepted Answer

Omeros Corporation (OMER) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Omeros Corporation is up from its 52 Week low?

Accepted Answer

Omeros Corporation (OMER) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Omeros Corporation?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Omeros Corporation

Accepted Answer

Dr. Gregory A. Demopulos M.D. is the current Chief Executive Officer (CEO) of Omeros Corporation.

Period	Omeros Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	-5.7%	5.1%	0.0%
6 Months	-19.47%	4.9%	0.0%
1 Year	7.22%	16.6%	0.0%
3 Years	-76.71%	13.2%	-22.3%

Market Capitalization	234.7M
Book Value	- $2.15
Earnings Per Share (EPS)	-3.32
PEG Ratio	-0.17
Wall Street Target Price	43.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-26.32%
Return On Equity TTM	-576.33%

Revenue TTM	-30.0M
Revenue Per Share TTM	-0.48
Quarterly Revenue Growth YOY	14.899999999999999%
Gross Profit TTM	-71.4M
EBITDA	-185.3M
Diluted Eps TTM	-3.32
Quarterly Earnings Growth YOY	0.0

Omeros Corporation (OMER)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs REGN

Vs NVO

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-3.02
EPS Estimate Next Year	-2.34
EPS Estimate Current Quarter	-1.14
EPS Estimate Next Quarter	-0.76

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Omeros Corporation	-12.29%	-19.47%	7.22%	-76.71%	-79.58%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Omeros Corporation	1.43	NA	-0.17	-3.02	-5.76	-0.26	NA	-2.15
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Omeros Corporation	Buy	$234.7M	-79.58%	1.43	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Omeros Corporation
Employees	198
CEO	Dr. Gregory A. Demopulos M.D.
Industry	Health Technology